ACHV
Price
$7.06
Change
-$0.22 (-3.02%)
Updated
Sep 11 closing price
Capitalization
726.49M
54 days until earnings call
Intraday BUY SELL Signals
AVXL
Price
$2.62
Change
-$0.04 (-1.50%)
Updated
Sep 11 closing price
Capitalization
243.33M
79 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs AVXL

ACHV vs AVXL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACHV vs. AVXL commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and AVXL is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($726M) has a higher market cap than AVXL($243M). ACHV YTD gains are higher at: 42.052 vs. AVXL (-26.404). AVXL has higher annual earnings (EBITDA): -12.92M vs. ACHV (-112.82M). ACHV has more cash in the bank: 187M vs. AVXL (118M). AVXL has less debt than ACHV: AVXL (88.2K) vs ACHV (14.9M). ACHV (0) and AVXL (0) have equivalent revenues.
ACHVAVXLACHV / AVXL
Capitalization726M243M299%
EBITDA-112.82M-12.92M873%
Gain YTD42.052-26.404-159%
P/E RatioN/AN/A-
Revenue00-
Total Cash187M118M158%
Total Debt14.9M88.2K16,893%
FUNDAMENTALS RATINGS
ACHV vs AVXL: Fundamental Ratings
ACHV
AVXL
OUTLOOK RATING
1..100
7356
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
3565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVXL's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for ACHV (81). This means that AVXL’s stock grew somewhat faster than ACHV’s over the last 12 months.

AVXL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ACHV (100). This means that AVXL’s stock grew similarly to ACHV’s over the last 12 months.

AVXL's SMR Rating (94) in the Biotechnology industry is in the same range as ACHV (100). This means that AVXL’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's Price Growth Rating (35) in the Biotechnology industry is in the same range as AVXL (65). This means that ACHV’s stock grew similarly to AVXL’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AVXL (100). This means that ACHV’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVAVXL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ACHV: $7.06 vs. AVXL: $2.62)
Brand notoriety: ACHV and AVXL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 94% vs. AVXL: 69%
Market capitalization -- ACHV: $726.49M vs. AVXL: $243.33M
ACHV [@Biotechnology] is valued at $726.49M. AVXL’s [@Biotechnology] market capitalization is $243.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green while AVXL’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • AVXL’s FA Score: 1 green, 4 red.
According to our system of comparison, AVXL is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while AVXL’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 4 bearish.
  • AVXL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than AVXL.

Price Growth

ACHV (@Biotechnology) experienced а -16.84% price change this week, while AVXL (@Biotechnology) price change was -8.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 05, 2026.

AVXL is expected to report earnings on Nov 30, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACHV
Daily Signal:
Gain/Loss:
AVXL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGIYX59.76N/A
N/A
Hartford Core Equity Y
TCREX19.17N/A
N/A
Nuveen Real Estate Sec Sel A
IGMAX7.10N/A
N/A
Voya Global Insights R
FAMDX22.85N/A
N/A
FAM Small Cap Institutional
SCMCX62.69N/A
N/A
Sterling Capital Mid Cp Relatv Val R6

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with TENX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-1.50%
TENX - AVXL
47%
Loosely correlated
-4.62%
AXON - AVXL
45%
Loosely correlated
+0.10%
MAZE - AVXL
45%
Loosely correlated
-0.89%
VCYT - AVXL
41%
Loosely correlated
-2.76%
ARRY - AVXL
41%
Loosely correlated
+1.54%
More